Tag: Cabozantinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Cabozantinib

Exelixis Inks Third Collaboration Deal in a Week, This Time with Catalent | BioSpace

Added to Collection on: 2022-11-03 15:42:58

Tags for this article:

Chemical compounds
Organic compounds
Exelixis
South San Francisco, California
Antineoplastic drugs
Cabozantinib
Protein kinase inhibitor
Genentech
Catalent
C-Met
Cobimetinib
Monoclonal antibody

Click the tags to see associated articles and topics

View Article Details
Exelixis/Roche combo fails to improve overall survival in NSCLC - PharmaLive

Added to Collection on: 2022-12-10 04:29:34

Tags for this article:

Cancer
Clinical medicine
Antineoplastic drugs
Lung cancer
Neoplasms
Genentech
Cabozantinib
Cyclopropanes
Exelixis
Atezolizumab
Protein kinase inhibitor
Non-small-cell lung carcinoma

Click the tags to see associated articles and topics

View Article Details
Mackenzie Financial Corp Takes $342000 Position in Exelixis, Inc. (NASDAQ:EXEL)

Added to Collection on: 2022-12-27 09:59:01

Tags for this article:

Economy
Finance
Money
Stock market
Financial markets
Equity securities
Exelixis
Short
Stock
Cabozantinib
Penny stock
Rate of return
Exelixis Inc.
Mackenzie Financial Corp

Click the tags to see associated articles and topics

View Article Details
Mackenzie Financial Corp Makes New Investment in Exelixis, Inc. (NASDAQ:EXEL)

Added to Collection on: 2022-12-27 09:50:24

Tags for this article:

Economy
Finance
Money
Financial markets
Equity securities
Stock market
Exelixis
Corporate finance
Short
Stock
Rate of return
Cabozantinib
Exelixis Inc.
Mackenzie Financial Corp

Click the tags to see associated articles and topics

View Article Details
This Drug Developer Is My Stock Cure for 2023 - RealMoney

Added to Collection on: 2022-12-29 15:19:25

Tags for this article:

Exelixis
Cabozantinib
Market capitalization
Chemical substances
Companies
Business

Click the tags to see associated articles and topics

View Article Details
Cambridge Investment Research Advisors Inc. Increases Stake in Exelixis, Inc. (NASDAQ:EXEL)

Added to Collection on: 2023-01-03 09:24:03

Tags for this article:

Financial markets
Finance
Economy
Equity securities
Stock market
Exelixis
Short
Cabozantinib
Stock
NASDAQ
Price?earnings ratio
Share
Exelixis Inc.
Cambridge Investment Research Advisors Inc.

Click the tags to see associated articles and topics

View Article Details
2 Stocks Under $30 to Buy and Hold - The Globe and Mail

Added to Collection on: 2024-02-19 13:37:53

Tags for this article:

Cyclopropanes
Quinolines
Corporate finance
Equity securities
Stock market
Exelixis
Adyen
Cabozantinib
PAYPAL
The Motley Fool
Zanzalintinib
Colorectal cancer

Click the tags to see associated articles and topics

View Article Details
Exploring the Need for Second-Line Treatments in Thyroid Cancer - Targeted Oncology

Added to Collection on: 2024-06-12 18:07:39

Tags for this article:

Orphan drugs
Cyclopropanes
Chloroarenes
Ureas
Tyrosine kinase inhibitors
Thyroid cancer
Cabozantinib
Anaplastic thyroid cancer
Protein kinase inhibitor
Sorafenib
Lenvatinib
Thyroid
Cesar Augusto Perez

Click the tags to see associated articles and topics

View Article Details
Exelixis shares get price target boost by Truist Securities - Investing.com

Added to Collection on: 2024-08-09 12:25:50

Tags for this article:

Financial markets
Financial ratios
Exelixis
Fluoroarenes
Quinolines
Tyrosine kinase inhibitors
Cabozantinib
PEG ratio
Valuation
Truist Financial
Short
Price?earnings ratio

Click the tags to see associated articles and topics

View Article Details
3 Magnificent Stocks Under $100 to Buy in November - The Globe and Mail

Added to Collection on: 2024-11-03 18:12:33

Tags for this article:

Exelixis
AstraZeneca
Cabozantinib
NASDAQ
Penny stock
Stock trader

Click the tags to see associated articles and topics

View Article Details